NIH-funded research NIH-funded research

Creating a toolkit to prevent youth overdoses

Official title: Adapting and Testing a Youth Overdose Prevention Toolkit

Funded at University of British Columbia · NIH-11055890 · Data updated 2026-11-12

This study is creating a helpful toolkit to prevent overdoses in young people aged 12 to 24, giving doctors in pediatric settings the tools they need to provide support and resources like naloxone and education about safe practices.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of British Columbia
NIH-funded
Lab location1 site (Vancouver, Canada)
Project startSeptember 30, 2024
Project endSeptember 29, 2027
Funding year2024
Award (this year)$572,368
NIH project number1R34DA062280-01
Project IDNIH-11055890 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include adolescents and young adults aged 12 to 24, particularly those from communities disproportionately affected by substance use and overdose.

Less likely to help

Patients outside the age range of 12 to 24 or those not affected by substance use issues may not benefit from this research.

What this research studies

This research aims to develop and test a youth overdose prevention toolkit tailored for adolescents and young adults aged 12 to 24. The toolkit will provide practical guidance for healthcare providers in pediatric settings, focusing on essential elements like naloxone distribution, harm reduction education, and medications for opioid use disorder. By engaging with communities in Boston and Vancouver, the project seeks to adapt existing evidence-based interventions to better meet the developmental needs of youth and improve their access to overdose prevention resources.

Why it matters

Potential benefit: If successful, this research could significantly reduce overdose deaths among youth by providing effective prevention strategies in healthcare settings.

How similar studies have gone: Previous research has shown success in implementing harm reduction strategies in youth populations, indicating a promising foundation for this novel approach.

Where this research is happening

  • University of British Columbia
    Vancouver, Canada
    Active

Researchers

  • Principal investigator: Fast, Danya — University of British Columbia
  • Study coordinator: Fast, Danya

Related research

Other NIH-funded projects on the same topics.

  • Ethno-epidemiological look at how Vancouver’s overdose Response works

    A Canadian research team studies how evolving drug use and supply changes affect overdose risk and how well current prevention and treatment efforts work for people who use fentanyl and stimulants.

    NIH research University of British Columbia · Vancouver, Canada · NIH-11402718

  • How changing drug supplies affect overdose risk and treatment in Vancouver

    This project looks at how shifts in drugs like fentanyl, stimulants, and novel psychoactive substances change overdose risk and treatment for people who use drugs in Vancouver.

    NIH research University of British Columbia · Vancouver, Canada · NIH-11088722

  • Understanding how violence affects HIV care for women

    This study looks at how experiences of gender-based violence affect the health and HIV care of cisgender and transgender women living with HIV, especially during the COVID-19 pandemic, and aims to create supportive programs to help these women get the care they need.

    NIH research University of British Columbia · Vancouver, Canada · NIH-10976423

  • Understanding tooth growth and loss using leopard geckos

    This study looks at how adult leopard geckos grow and lose their teeth, which might help us understand dental health in people, especially when it comes to how teeth come in and fall out.

    NIH research University of British Columbia · Vancouver, Canada · NIH-10953437

  • Evaluating a program that tests illicit drugs to help prevent overdoses.

    This study is looking at a program in British Columbia that lets people test their drugs for dangerous substances like fentanyl, helping them make safer choices and reduce the risk of overdose.

    NIH research University of British Columbia · Vancouver, Canada · NIH-10676189

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.